Patients with post polycythemia vera myelofibrosis might experience increased thrombotic risk in comparison to primary and post essential thrombocythemia myelofibrosis
Leuk Res. 2022 Aug:119:106905.
doi: 10.1016/j.leukres.2022.106905.
Epub 2022 Jun 21.
1 Hematology Department, University Hospital Dubrava, Av. Gojka Suska 6, 10000 Zagreb, Croatia; University of Zagreb School of Medicine, Ul. Salata 3, 10000 Zagreb, Croatia. Electronic address: markolucijanic@yahoo.com.
2 Department of Internal Medicine, General Hospital Sibenik, Ul. Stjepana Radica 83, 22000 Sibenik, Croatia; University of Rijeka School of Medicine, Ul. Brace Branchetta 20/1, 51000 Rijeka, Croatia.
3 Hematology Department, University Hospital Dubrava, Av. Gojka Suska 6, 10000 Zagreb, Croatia.
4 Department of Hematology, University Hospital of Split, Soltanska ul. 1, 21000 Split, Croatia; University of Split School of Medicine, Soltanska ul. 2, 21000 Split, Croatia.
5 Department of Internal Medicine, "Dr. Josip Bencevic" General Hospital, Ul. Andrije Stampara, 35000 Slavonski Brod, Croatia; University of Osijek Faculty of Medicine, Ul. Josipa Huttlera 4, 31000 Osijek, Croatia.
6 University of Osijek Faculty of Medicine, Ul. Josipa Huttlera 4, 31000 Osijek, Croatia; Department of Hematology, Osijek University Hospital, Ul. Josipa Huttlera 4, 31000 Osijek, Croatia.
7 Department of Internal Medicine, General Hospital Zadar, Ul. Boze Pericica 5, 23000 Zadar, Croatia.
8 Hematology Department, University Hospital Dubrava, Av. Gojka Suska 6, 10000 Zagreb, Croatia; University of Zagreb School of Medicine, Ul. Salata 3, 10000 Zagreb, Croatia.